Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics, safety and effectiveness of remimazolam versus propofol for intravenous anesthesia
ChiCTR2100043396Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (2 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: Remimazolam blood concentration. Started Mar 2021; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100043396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043396.